Michael Redman

Michael Redman

Directeur Général chez
Theratome Bio, Inc.
71 ans
Health Technology
Commercial Services
Consumer Services

Profil

Michael T.
Redman
was the founder of Opexa Pharmaceuticals, Inc., founded in 2001, where the title held was Chief Executive Officer from 2001 to 2005.
Mr. Redman was the founder of Oncolix, Inc., founded in 2006, where the title held was Chief Executive Officer & Director.
Mr. Redman is currently Chief Executive Officer at Theratome Bio, Inc. Mr. Redman is currently Chief Executive Officer & Director at GreenJay Therapeutics, Inc., starting in 2022.
Former positions include President, Chief Executive Officer, CFO & Director at Advanced Environmental Petroleum Producers, Inc.; Chief Executive Officer at Botanix Pharmaceuticals Ltd.; Director at Oncolix, Inc. from 2006 to 2019; Principal at Wyeth LLC; Principal at Repros Therapeutics, Inc.; Principal at Aronex Pharmaceuticals, Inc.; Chief Operating Officer & Executive Vice President at Genprex, Inc. from 2020 to 2021; Member at Licensing Executives Society; and Principal at Biovail Pharmaceuticals LLC.
Education includes undergraduate studies at the University of Missouri and an MBA from the University of Phoenix.

Postes actifs de Michael Redman

SociétésPosteDébut
Directeur Général -

Anciens postes connus de Michael Redman

SociétésPosteFin
GENPREX, INC. Directeur des opérations 15/10/2021
ONCOLIX, INC. Directeur Général -
Directeur Général 01/01/2005
Corporate Officer/Principal -
Directeur Général -
Voir l'expérience en détail de Michael Redman

Formation de Michael Redman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

26

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michael Redman